5-oxo-1-2-4-oxadiazol biphenyl
5-oxo-1-2-4-oxadiazol biphenyl
| SMILES |
CCC[C@@H](C(=O)O)N(Cc1ccc(-c2ccccc2-c2noc(=O)[nH]2)cc1)C(=O)CC |
| InChIKey |
FXELTRKWYHPHAE-IBGZPJMESA-N |
Chemical Properties
| Hydrogen bond acceptors |
5 |
| Hydrogen bond donors |
2 |
| Rotatable bonds |
9 |
| Molecular weight (Da) |
423.2 |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
5-oxo-1-2-4-oxadiazol biphenyl
Drug properties
| Molecular type |
Small molecule |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
Compound is not listed as a drug.